Skin Cancers Terminated Phase 2 Trials for Aldesleukin (DB00041)

Also known as: Cancer of Skin / Skin Cancer / [X]Malignant neoplasm of skin, unspecified / Skin malignant neoplasm NOS / Malignant skin neoplasm NOS / Skin neoplasms malignant and unspecified / Skin neoplasm malignant NOS / Skin neoplasm malignant

DBCOND0046599 (Skin Cancers)Terminated2 IdentifierTitlePurposeDrugs
NCT02111863Immunotherapy Using 41BB Selected Tumor Infiltrating Lymphocytes for Patients With Metastatic MelanomaTreatment
NCT00509496Phase II Study of Metastatic Melanoma With Lymphodepleting Conditioning and Anti-gp100:154-162 TCR Gene Engineered LymphocytesTreatment
NCT00610311Anti-gp100 Cells Plus ALVAC gp100 Vaccine to Treat Advanced MelanomaTreatment
NCT00612222Anti-MART-1 F5 Cells Plus ALVAC MART-1 Vaccine to Treat Advanced MelanomaTreatment
NCT01495572Melanoma Treatment With White Blood Cells That Destroy MART Expressing Tumor CellsTreatment